Skip to content

A study to assess the cortical reactivity of unipolar depression and bipolar disorder based on TMS-EEG technology

A study to assess the cortical reactivity of unipolar depression and bipolar disorder based on TMS-EEG technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049725
Enrollment
Unknown
Registered
2021-08-08
Start date
2021-08-03
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Bipolar disorder

Interventions

Sponsors

Beijing Anding Hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. The selected patients are 18-60 years old, gender-neutral, right-handed; meet the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders: (Diagnostic and Statistical Manual of Mental Disorders, DSM-IV) depressive episode, bipolar I type disorder, which is currently the diagnostic criteria for depressive episodes and schizophrenia; 2. Depressed patients meet the Hamilton Depression Scale (HAMD-17) score >= 17; 3. Patients included in this experimental study sample should stop taking benzodiazepines 8 hours before electrophysiological assessment; 4. Participants who participated in this study signed the informed consent form of this experiment to be included in this study.

Exclusion criteria

Exclusion criteria: 1. There is a serious mental disorder or neurological disease other than the diseases in the inclusion criteria, or there is alcohol or substance dependence, or there is a language ability disorder and cannot effectively complete the test; 2. Mental retardation; 3. Impulsive, excited, uncooperative; 4. Pregnant or lactating women; 5. Diagnosed with epilepsy, or the individual has a history of epileptic seizures, or the patient's first-degree relatives have a history of epilepsy, taking drugs associated with an increased risk of epilepsy or are on medication; 6. Has undergone brain surgery with the presence of intracranial implants.

Design outcomes

Primary

MeasureTime frame
EEG resting-state neural oscillations;EEG task state neural oscillations;Magnetic resonance spectroscopy;

Secondary

MeasureTime frame
Time-frequency analysis of EEG features;Correlation analysis of data with clinical characteristics;

Countries

China

Contacts

Public ContactJia Lina

Beijing Anding Hospital

lnjia@ccmu.edu.cn+86 15901588600

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026